分组1 - RadNet reported quarterly earnings of $0.23 per share, exceeding the Zacks Consensus Estimate of $0.19 per share, and showing an increase from $0.22 per share a year ago, resulting in an earnings surprise of +22.67% [1] - The company achieved revenues of $547.71 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 6.28%, and up from $477.1 million year-over-year [2] - Over the last four quarters, RadNet has surpassed consensus EPS estimates two times and topped consensus revenue estimates four times [2] 分组2 - The stock has underperformed the market with a loss of about 2.2% since the beginning of the year, compared to the S&P 500's gain of 0.5% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.12 on revenues of $533.53 million, and for the current fiscal year, it is $0.73 on revenues of $2.26 billion [7] - The Zacks Industry Rank for Medical - Outpatient and Home Healthcare is currently in the bottom 27% of over 250 Zacks industries, indicating potential challenges for the sector [8]

Core Insights - LifeStance Health Group (LFST) reported break-even quarterly earnings per share, surpassing the Zacks Consensus Estimate of a loss of $0.01, and showing improvement from a loss of $0.02 per share a year ago, resulting in an earnings surprise of +100.00% [1] - The company achieved revenues of $363.81 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 2.30% and up from $312.72 million in the same quarter last year [2] - LifeStance Health has outperformed consensus EPS estimates in all four quarters over the past year and has topped revenue estimates three times during the same period [2] Financial Performance - The company's shares have declined approximately 34.7% since the beginning of the year, contrasting with the S&P 500's gain of 15.6% [3] - The current consensus EPS estimate for the upcoming quarter is breakeven on revenues of $383.44 million, while for the current fiscal year, the estimate is -$0.02 on revenues of $1.42 billion [7] Industry Outlook - The Medical - Outpatient and Home Healthcare industry, to which LifeStance Health belongs, is currently ranked in the top 19% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]